Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation

European Journal of Neuroscience

Volumn 25, Issue 7, 2007, Pages 1923-1930

  Koh, Seong Ho ^a   Kim, Youngchul ^a   Kim, Hyun Young ^a   Won Cho, Goang ^a   Kim, Kyung Sook ^a   Kim, Seung H ^a  

^a Hanyang University   (South Korea)

Author keywords

ALS; Erythropoietin; Inflammation; Neuronal cell death

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; EPORON; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; LIFESPAN; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFLAMMATION; MICE; MICE, TRANSGENIC; MOTOR NEURONS; ROTAROD PERFORMANCE TEST; SPINAL CORD; SUPEROXIDE DISMUTASE; SURVIVAL RATE;

EID: 34147199187     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05471.x     Document Type: Article

References (32)

1. Agnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M.L. & Ghezzi, P. (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res., 952, 128-134.
2. Andreassen, O.A., Dedeoglu, A., Friedlich, A., Ferrante, K.L., Hughes, D., Szabo, C. & Beal, M.F. (2001) Effects of an inhibitor of poly (ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp. Neurol., 168, 419-424.
3. Beers, D.R., Ho, B.K., Siklos, L., Alexianu, M.E., Mosier, D.R., Mohamed, A.H., Otsuka, Y., Kozovska, M.E., McAlhany, R.E., Smith, R.G. & Appel, S.H. (2001) Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem., 79, 499-509.
4. Brettschneider, J., Widl, K., Ehrenreich, H., Riepe, M. & Tumani, H. (2006) Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci. Lett., 404, 347-351.
5. Celik, M., Gokmen, N., Erbayraktar, S., Akhisaroglu, M., Konakc, S., Ulukus, C., Genc, S., Genc, K., Sagiroglu, E., Cerami, A. & Brines, M. (2002) Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl Acad. Sci. USA, 99, 2258-2263.
6. Cudkowicz, M.E., Shefner, J.M., Schoenfeld, D.A., Zhang, H., Andreasson, K.I., Rothstein, J.D. & Drachman, D.B. (2006) Trial of celecoxib in amyotrophic lateral sclerosis. Ann. Neurol., 60, 22-31.
7. Drachman, D.B., Frank, K., Dykes-Hoberg, M., Teismann, P., Almer, G., Przedborski, S. & Rothstein, J.D. (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol., 52, 771-778.
8. Engelhardt, J.I. & Appel, S.H. (1990) IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol., 47, 1210-1216.
9. Engelhardt, J.I., Tajti. J. & Appel, S.H. (1993) Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol., 50, 30-36.
10. Genc, S., Akhisaroglu, M., Kuralay, F. & Genc, K. (2002) Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1, 2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci. Lett., 321, 73-76.
11. Gorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., Di Giulio, A.M., Vardar, E., Cerami, A. & Brines, M. (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl Acad. Sci. USA, 99, 9450-9455.
12. Grewal, R.P., Morgan, T.E. & Finch, C.E. (1999) C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci. Lett., 271, 65-67.
13. Henkel, J.S., Engelhardt, J.I., Siklos, L., Simpson, E.P., Kim, S.H., Pan, T., Goodman, J.C., Siddique, T., Beers, D.R. & Appel, S.H. (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol., 55, 221-235.
14. Kaspar, B.K., Llado, J., Sherkat, N., Rothstein, J.D. & Gage, F.H. (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301, 839-842.
15. Kieran, D., Kalmar, B., Dick, J.R., Riddoch-Contreras, J., Burnstock, G. & Greensmith, L. (2004) Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med., 10, 402-405.
16. Klivenyi, P., Kiaei, M., Gardian, G., Calingasan, N.Y. & Beal, M.F. (2004) Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem., 88, 576-582.
17. Koh, S.H., Lee, S.M., Kim, H.Y., Lee, K.Y., Lee, Y.J., Kim, H.T., Kim, J., Kim, M.H., Hwang, M.S., Song, C., Yang, K.W., Lee, K.W., Kim, S.H. & Kim, O.H. (2006) The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett., 395, 103-107.
18. Koh, S.H., Roh, H., Lee, S.M., Kim, H.J., Kim, M., Lee, K.W., Kim, H.T., Kim, J. & Kim, S.H. (2005) Phosphatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene. Toxicology, 213, 45-55.
19. Kriz, J., Gowing, G. & Julien, J.P. (2003) Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann. Neurol., 53, 429-436.
20. Lampson, L.A., Kushner, P.D. & Sobel, R.A. (1990) Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann. Neurol., 28, 365-372.
21. Mayeux, P., Dusanter-Fourt, I., Muller, O., Mauduit, P., Sabbah, M., Druker, B., Vainchenker, W., Fischer, S., Lacombe, C. & Gisselbrecht, S. (1993) Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur. J. Biochem., 216, 821-828.
22. McLeod, M., Hong, M., Mukhida, K., Sadi, D., Ulalia, R. & Mendez, I. (2006) Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur. J. Neurosci., 24, 361-370.
23. Mori, K.J., Smadja-Joffe, F., Dorval, T. & Jasmin, C. (1980) Induction of erythropoiesis with erythrocyte production in bone marrow cell culture 'in vitro'. Biomedicine, 33, 148-150.
24. Nagano, I., Murakami, T., Manabe, Y. & Abe, K. (2002) Early decrease of survival factors and DNA repair enzyme in spinal motor neurons of presymptomatic transgenic mice that express a mutant SOD1 gene. Life Sci., 72, 541-548.
25. Pompl, P.N., Ho, L., Bianchi, M., McManus, T., Qin, W. & Pasinetti, G.M. (2003) A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J., 17, 725-727.
26. Sasaki, S., Shibata, N., Komori, T. & Iwata, M. (2000) iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci. Lett., 291, 44-48.
27. Sugai, F., Yamamoto, Y., Miyaguchi, K., Zhou, Z., Sumi, H., Hamasaki, T., Goto, M. & Sakoda, S. (2004) Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur. J. Neurosci., 20, 3179-3183.
28. Sun, Y., Calvert, J.W. & Zhang, J.H. (2005) Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke, 36, 1672-1678.
29. Villa, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T.R., Brines, M. & Ghezzi, P. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med., 198, 971-975.
30. Warita, H., Manabe, Y., Murakami, T., Shiro, Y., Nagano, I. & Abe, K. (2001) Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene. Apoptosis, 6, 345-352.
31. Yasojima, K., Tourtellotte, W.W., McGeer, E.G. & McGeer, P.L. (2001) Marked increase in cyclooxygenase-2 in ALS spinal cord. Neurology, 57, 952-956.
32. Zheng, C., Nennesmo, I., Fadeel, B. & Henter, J.I. (2004) Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol., 56, 564-567. .